MedPath

The effect of inulin on rheumatoid arthritis

Phase 3
Recruiting
Conditions
Rheumatoid arthritis.
Rheumatoid arthritis, unspecified
M06.9
Registration Number
IRCT20230506058098N1
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Age between 30 and 65 years
Willingness to participate in the study and complete the consent form before starting the supplement therapy
Not taking herbal and medicinal supplements, especially antioxidant supplements, in the three months before the start of the study

Exclusion Criteria

Pregnancy and breastfeeding
smoking
Following a special diet
Taking drugs that affect the digestive microbiome, including antibiotics, proton pump inhibitors, and probiotic and prebiotic supplements in the last three months
Inflammatory bowel diseases (Crohn's and ulcerative colitis)
Using traditional medicine methods in the last 3 months
Infectious rheumatoid arthritis

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of rheumatoid arthritis. Timepoint: Measuring the severity of rheumatoid arthritis at the beginning of the study (before the start of the intervention) and 60 days after the start of taking the supplement (the end of the intervention). Method of measurement: Blood tests and questionnaires related to the severity of rheumatoid arthritis.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath